ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+9.87%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$299M
AUM Growth
+$299M
(-0.16%)
Cap. Flow
-$28.5M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
39.8%
Holding
92
New
15
Increased
30
Reduced
32
Closed
15
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$10.1M |
| 2 |
Encompass Health
EHC
|
$8.46M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$6.36M |
| 4 |
Biogen
BIIB
|
$5.49M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$4.67M |
Top Sells
| 1 |
Globus Medical
GMED
|
$11.4M |
| 2 |
Thermo Fisher Scientific
TMO
|
$11.3M |
| 3 |
Merck
MRK
|
$10.2M |
| 4 |
Becton Dickinson
BDX
|
$8.92M |
| 5 |
STJ
St Jude Medical
STJ
|
$7.33M |
Sector Composition
| 1 | Healthcare | 89.39% |
| 2 | Financials | 3.11% |
| 3 | Technology | 0.63% |
| 4 | Industrials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $21.7M | 7.24% | 330,033 +96,933 | +42% | +$6.36M |
|
|
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $16.5M | 5.53% | 221,529 +62,520 | +39% | +$4.67M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $13.6M | 4.54% | 132,405 +98,705 | +293% | +$10.1M |
|
|
4
Encompass Health
EHC
$12.3B
| $12.7M | 4.24% | 364,290 +242,990 | +200% | +$8.46M |
|
5
Medtronic
MDT
$119B
| $10.1M | 3.36% | 130,666 +26,348 | +25% | +$2.03M |
|
|
6
Biogen
BIIB
$19.4B
| $9.66M | 3.23% | 31,532 +17,920 | +132% | +$5.49M |
|
|
AET
7
DELISTED
Aetna Inc
AET
| $9.3M | 3.11% | 86,015 -14,835 | -15% | -$1.6M |
|
|
BXLT
8
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $8.59M | 2.87% | 220,125 +70,425 | +47% | +$2.75M |
|
9
UnitedHealth
UNH
$281B
| $8.53M | 2.85% | 72,506 -12,294 | -14% | -$1.45M |
|
10
Viatris
VTRS
$12.3B
| $8.44M | 2.82% | 156,020 +47,920 | +44% | +$2.59M |
|
|
SPNC
11
DELISTED
Spectranetics Corp
SPNC
| $8.37M | 2.8% | 555,766 -7,884 | -1% | -$119K |
|
|
STJ
12
DELISTED
St Jude Medical
STJ
| $7.84M | 2.62% | 126,881 -118,645 | -48% | -$7.33M |
|
|
13
Becton Dickinson
BDX
$55.3B
| $7.65M | 2.56% | 49,617 -57,876 | -54% | -$8.92M |
|
|
AGN
14
DELISTED
Allergan plc
AGN
| $7.38M | 2.47% | 23,600 -21,966 | -48% | -$6.86M |
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $6.97M | 2.33% | 79,727 +3,540 | +5% | +$309K |
|
16
McKesson
MCK
$85.4B
| $6.23M | 2.08% | 31,571 +22,402 | +244% | +$4.42M |
|
|
17
Thermo Fisher Scientific
TMO
$186B
| $5.98M | 2% | 42,145 -79,429 | -65% | -$11.3M |
|
18
AbbVie
ABBV
$372B
| $5.17M | 1.73% | 87,300 +70,900 | +432% | +$4.2M |
|
19
Abbott
ABT
$231B
| $5.16M | 1.73% | 114,984 -1,621 | -1% | -$72.8K |
|
20
Stryker
SYK
$150B
| $5.15M | 1.72% | 55,460 -34,826 | -39% | -$3.24M |
|
21
Boston Scientific
BSX
$156B
| $5.09M | 1.7% | 276,098 +21,398 | +8% | +$395K |
|
22
Centene
CNC
$14.3B
| $4.88M | 1.63% | 74,138 -7,226 | -9% | -$476K |
|
|
NVRO
23
DELISTED
NEVRO CORP.
NVRO
| $4.59M | 1.54% | 68,052 -37,248 | -35% | -$2.51M |
|
24
HCA Healthcare
HCA
$94.5B
| $4.48M | 1.5% | 66,225 -37,800 | -36% | -$2.56M |
|
25
Standard BioTools
LAB
$481M
| $4.36M | 1.46% | 403,290 -94,478 | -19% | -$1.02M |
|